Key result
Over 5 years, healthcare costs for heart failure with normal ejection fraction were similar to abnormal ejection fraction for both incident ($45,604 vs $49,128) and prevalent ($32,580 vs $33,023) cases.
Why the study?
Are the 5-year costs of heart failure with normal ejection fraction similar to those with reduced ejection fraction in an elderly population?
Cohort (n=881)
Are the 5-year costs of heart failure with normal ejection fraction similar to those with reduced ejection fraction in an elderly population?
Absolute Event Rate: 45604% vs 49128%
p-value: p=0.55
Heart failure with normal ejection fraction imposes a financial burden comparable to heart failure with reduced ejection fraction over a 5-year period among the elderly.
No takes yet. Share an insight, caveat, or question.
Supports equivalent resource planning for elderly HFpEF and HFrEF; hypothesis-generating for cost-effectiveness trials by EF subtype.
Lawrence Liao (2006) conducted a cohort in Heart failure (n=881). Heart failure with normal ejection fraction vs. Heart failure with abnormal ejection fraction was evaluated on Mean costs per subject for a 5-year period (p=0.55). Over 5 years, healthcare costs for heart failure with normal ejection fraction were similar to abnormal ejection fraction for both incident ($45,604 vs $49,128) and prevalent ($32,580 vs $33,023) cases.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: